# PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin

> **NCT04856683** · — · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 1100 (estimated)

## Conditions studied

- Frailty

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04856683
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-10
- **Primary completion:** 2023-08
- **Final completion:** 2024-08-09
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2022-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04856683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04856683, "PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04856683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*